From stem cells to oligodendrocytes: prospects for brain therapy.
Multiple sclerosis is an autoimmune disease that destroys myelin-forming oligodendrocytes of the CNS. While the damage can be partially controlled using anti-inflammatory cytokines and steroids, endogenous repair is insufficient to replace lost cells. Until now cell replenishment (transplant therapy) has been viewed as unlikely to succeed due to allograft rejection in this sensitized immune environment. However, advances in stem cell biology give new hope for deriving patient-specific, autologous oligodendrocytes which may tip the balance to favor repair. The challenge will be to engineer these cells to respond to cues that can target their migration into lesions for brain and spinal cord repair.
Department of Surgery (Neurosurgery), UMDNJ-Robert Wood Johnson Medical School, 675 Hoes Lane, S-225, Piscataway, NJ, 08854, USA.
Cui P
CP
Chen
Mary E
ME
Kiel
Dorota
D
Sadowski
Randall D
RD
McKinnon
D000818:Animals; D001927:Brain Diseases / Q000473:pathology / Q000628:therapy*; D002454:Cell Differentiation; D002465:Cell Movement; D006801:Humans; D051379:Mice; D009103:Multiple Sclerosis / Q000473:pathology / Q000628:therapy; D009186:Myelin Sheath / Q000473:pathology; D009416:Nerve Regeneration; D009836:Oligodendroglia / Q000166:cytology / Q000637:transplantation*; D033581:Stem Cell Transplantation / Q000379:methods*; D023822:Tissue Engineering / Q000379:methods